Hsp90 inhibitors as novel cancer chemotherapeutic agents
- 1 April 2002
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 8 (4), S55-S61
- https://doi.org/10.1016/s1471-4914(02)02316-x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3ηMolecular and Cellular Endocrinology, 2001
- The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the ChaperoneJournal of Biological Chemistry, 2000
- Induction of Heat Shock Proteins by Tyrosine Kinase Inhibitors in Rat Cardiomyocytes and Myogenic Cells Confers Protection Against Simulated IschemiaJournal of Molecular and Cellular Cardiology, 1997
- The hsp90-binding Antibiotic Geldanamycin Decreases Raf Levels and Epidermal Growth Factor Signaling without Disrupting Formation of Signaling Complexes or Reducing the Specific Enzymatic Activity of Raf KinasePublished by Elsevier BV ,1997
- Hsp90 Regulates Androgen Receptor Hormone Binding Affinity in VivoPublished by Elsevier BV ,1996
- Pre-Conditioning of Smooth Muscle Cells via Induction of the Heat Shock Response Limits Proliferation Following Mechanical InjuryBiochemical and Biophysical Research Communications, 1996
- Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.Genes & Development, 1996
- Binding of Benzoquinoid Ansamycins to p100 Correlates with Their Ability to Deplete the erbB2 Gene Product p185Biochemical and Biophysical Research Communications, 1994
- Unusual expression and localization of heat‐shock proteins in human tumor cellsInternational Journal of Cancer, 1992